|
|
||||||||||
|
J Am Coll Cardiol, 2003; 41:879-888, doi:10.1016/S0735-1097(03)00081-0 © 2003 by the American College of Cardiology Foundation |



* Section of Cardiac Surgery, University of Michigan, Ann Arbor, MI, USA
Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA
Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA
Temple University, Philadelphia, Pennsylvania, USA
¶ Diacrin, Inc., Charlestown, Massachusetts, USA
Manuscript received October 20, 2002; revised manuscript received January 19, 2003, accepted January 23, 2003.
* Reprint requests and correspondence: Dr. Francis D. Pagani, Associate Professor of Surgery, Director, Heart Transplant Program, Section of Cardiac Surgery, 2120 Taubman Center, Box 3480, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109, USA.
fpagani{at}umich.edu
OBJECTIVES: We report histological analysis of hearts from patients with end-stage heart disease who were transplanted with autologous skeletal myoblasts concurrent with left ventricular assist device (LVAD) implantation.
BACKGROUND: Autologous skeletal myoblast transplantation is under investigation as a means to repair infarcted myocardium. To date, there is only indirect evidence to suggest survival of skeletal muscle in humans.
METHODS: Five patients (all male; median age 60 years) with ischemic cardiomyopathy, refractory heart failure, and listed for heart transplantation underwent muscle biopsy from the quadriceps muscle. The muscle specimen was shipped to a cell isolation facility where myoblasts were isolated and grown. Patients received a transplant of 300 million cells concomitant with LVAD implantation. Four patients underwent LVAD explant after 68, 91, 141, and 191 days of LVAD support (three transplant, one LVAD death), respectively. One patient remains alive on LVAD support awaiting heart transplantation.
RESULTS: Skeletal muscle cell survival and differentiation into mature myofibers were directly demonstrated in scarred myocardium from three of the four explanted hearts using an antibody against skeletal muscle-specific myosin heavy chain. An increase in small vessel formation was observed in one of three patients at the site of surviving myotubes, but not in adjacent tissue devoid of engrafted cells.
CONCLUSIONS: These findings represent demonstration of autologous myoblast cell survival in human heart. The implanted skeletal myoblasts formed viable grafts in heavily scarred human myocardial tissue. These results establish the feasibility of myoblast transplants for myocardial repair in humans.
| ||||||||||
This article has been cited by other articles:
![]() |
S. Aharinejad, D. Abraham, P. Paulus, K. Zins, M. Hofmann, W. Michlits, M. Gyongyosi, K. Macfelda, T. Lucas, K. Trescher, et al. Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation Cardiovasc Res, August 1, 2008; 79(3): 395 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Veltman, O. I.I. Soliman, M. L. Geleijnse, W. B. Vletter, P. C. Smits, F. J. ten Cate, L. J. Jordaens, A. H.H.M. Balk, P. W. Serruys, E. Boersma, et al. Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy Eur. Heart J., June 1, 2008; 29(11): 1386 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. Traktuev, S. Merfeld-Clauss, J. Li, M. Kolonin, W. Arap, R. Pasqualini, B. H. Johnstone, and K. L. March A Population of Multipotent CD34-Positive Adipose Stromal Cells Share Pericyte and Mesenchymal Surface Markers, Reside in a Periendothelial Location, and Stabilize Endothelial Networks Circ. Res., January 4, 2008; 102(1): 77 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Gallegos and R. M. Bolman III Stem Cell Induced Regeneration of Myocardium Card. Surg. Adult, January 1, 2008; 3(2008): 1657 - 1668. [Full Text] |
||||
![]() |
C. Guo, H. Kh. Haider, W. S.N. Shim, R.-S. Tan, L. Ye, S. Jiang, P. K. Law, P. Wong, and E. K.W. Sim Myoblast-based cardiac repair: xenomyoblast versus allomyoblast transplantation. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1332 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Khan, V. K. Kutala, D. S. Vikram, S. Wisel, S. M. Chacko, M. L. Kuppusamy, I. K. Mohan, J. L. Zweier, P. Kwiatkowski, and P. Kuppusamy Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2129 - H2139. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Singla, G. E. Lyons, and T. J. Kamp Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1308 - H1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kondoh, Y. Sawa, N. Fukushima, G. Matsumiya, S. Miyagawa, S. Kitagawa-Sakakida, Y. Imanishi, N. Kawaguchi, N. Matsuura, and H. Matsuda Combined Strategy Using Myoblasts and Hepatocyte Growth Factor in Dilated Cardiomyopathic Hamsters Ann. Thorac. Surg., July 1, 2007; 84(1): 134 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Prockop and S. D. Olson Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions Blood, April 15, 2007; 109(8): 3147 - 3151. [Full Text] [PDF] |
||||
![]() |
M. I. Niagara, H. Kh. Haider, S. Jiang, and M. Ashraf Pharmacologically Preconditioned Skeletal Myoblasts Are Resistant to Oxidative Stress and Promote Angiomyogenesis via Release of Paracrine Factors in the Infarcted Heart Circ. Res., March 2, 2007; 100(4): 545 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wisel, S. M. Chacko, M. L. Kuppusamy, R. P. Pandian, M. Khan, V. K. Kutala, R. W. Burry, B. Sun, P. Kwiatkowski, and P. Kuppusamy Labeling of skeletal myoblasts with a novel oxygen-sensing spin probe for noninvasive monitoring of in situ oxygenation and cell therapy in heart Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1254 - H1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bonaros, R. Rauf, D. Wolf, E. Margreiter, A. Tzankov, B. Schlechta, A. Kocher, H. Ott, T. Schachner, S. Hering, et al. Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1321 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Siminiak, E. Meliga, O. Jerzykowska, and P. W. Serruys Percutaneous transplantation of skeletal myoblast in the treatment of post-infarction injury Eur. Heart J. Suppl., December 1, 2006; 8(suppl_H): H57 - H64. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Wu, Y. L. Liu, B. Zhou, and Z. C. Han Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 770 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hata, G. Matsumiya, S. Miyagawa, H. Kondoh, N. Kawaguchi, N. Matsuura, T. Shimizu, T. Okano, H. Matsuda, and Y. Sawa Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 918 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Caspi and L. Gepstein Stem cells for myocardial repair Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E43 - E54. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gavira, M. Perez-Ilzarbe, G. Abizanda, A. Garcia-Rodriguez, J. Orbe, J. A. Paramo, M. Belzunce, G. Rabago, J. Barba, J. Herreros, et al. A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction Cardiovasc Res, September 1, 2006; 71(4): 744 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Boyle, S. P. Schulman, and J. M. Hare Stem Cell Therapy for Cardiac Repair: Ready for the Next Step Circulation, July 25, 2006; 114(4): 339 - 352. [Full Text] [PDF] |
||||
![]() |
P. Oettgen Cardiac Stem Cell Therapy: Need for Optimization of Efficacy and Safety Monitoring Circulation, July 25, 2006; 114(4): 353 - 358. [Full Text] [PDF] |
||||
![]() |
C. E. Murry, H. Reinecke, and L. M. Pabon Regeneration Gaps: Observations on Stem Cells and Cardiac Repair J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1777 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Serruys Fourth Annual American College of Cardiology International Lecture: A Journey in the Interventional Field J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1754 - 1768. [Full Text] [PDF] |
||||
![]() |
J. J. Gavira, J. Herreros, A. Perez, M. J. Garcia-Velloso, J. Barba, F. Martin-Herrero, C. Canizo, A. Martin-Arnau, J. M. Marti-Climent, M. Hernandez, et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 799 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fernandes, J.-C. Amirault, G. Lande, J.-M. Nguyen, V. Forest, O. Bignolais, G. Lamirault, D. Heudes, J.-L. Orsonneau, M.-F. Heymann, et al. Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias Cardiovasc Res, February 1, 2006; 69(2): 348 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Pennington The Impact of New Technology on Cardiothoracic Surgical Practice Ann. Thorac. Surg., January 1, 2006; 81(1): 10 - 18. [Full Text] [PDF] |
||||
![]() |
L. Ye, H. K. Haider, and E. K. W. Sim Adult Stem Cells for Cardiac Repair: A Choice Between Skeletal Myoblasts and Bone Marrow Stem Cells Experimental Biology and Medicine, January 1, 2006; 231(1): 8 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Minguell and A. Erices Mesenchymal Stem Cells and the Treatment of Cardiac Disease Experimental Biology and Medicine, January 1, 2006; 231(1): 39 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Patel, L. Geffner, R. F. Vina, J. Saslavsky, H. C. Urschel Jr, R. Kormos, and F. Benetti Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: A prospective randomized study J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1631 - 1638. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Murry, L. J. Field, and P. Menasche Cell-Based Cardiac Repair: Reflections at the 10-Year Point Circulation, November 15, 2005; 112(20): 3174 - 3183. [Full Text] [PDF] |
||||
![]() |
I. A. Memon, Y. Sawa, N. Fukushima, G. Matsumiya, S. Miyagawa, S. Taketani, S. K. Sakakida, H. Kondoh, A. N. Aleshin, T. Shimizu, et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1333 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, S. Fazel, H. Tian, D. A. G. Mickle, R. D. Weisel, T. Fujii, and R.-K. Li Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2089 - H2096. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. McConnell, C. L. del Rio, D. B. Jacoby, M. Pavlicova, P. Kwiatkowski, A. Zawadzka, J. H. Dinsmore, L. Astra, S. Wisel, and R. E. Michler Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1001 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yaoita, S. Takase, Y. Maruyama, Y. Sato, H. Satokawa, N. Hoshi, N. Ono, T. Igari, H. Ohto, and H. Yokoyama Scintigraphic Assessment of the Effects of Bone Marrow-Derived Mononuclear Cell Transplantation Combined with Off-Pump Coronary Artery Bypass Surgery in Patients with Ischemic Heart Disease J. Nucl. Med., October 1, 2005; 46(10): 1610 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dib, R. E. Michler, F. D. Pagani, S. Wright, D. J. Kereiakes, R. Lengerich, P. Binkley, D. Buchele, I. Anand, C. Swingen, et al. Safety and Feasibility of Autologous Myoblast Transplantation in Patients With Ischemic Cardiomyopathy: Four-Year Follow-Up Circulation, September 20, 2005; 112(12): 1748 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Chachques, C. Salanson-Lajos, P. Lajos, A. Shafy, A. Alshamry, and A. Carpentier Cellular Cardiomyoplasty for Myocardial Regeneration Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 287 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Itabashi, S. Miyoshi, S. Yuasa, J. Fujita, T. Shimizu, T. Okano, K. Fukuda, and S. Ogawa Analysis of the electrophysiological properties and arrhythmias in directly contacted skeletal and cardiac muscle cell sheets Cardiovasc Res, August 15, 2005; 67(3): 561 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Siepe, C. Heilmann, P. von Samson, P. Menasche, and F. Beyersdorf Stem cell research and cell transplantation for myocardial regeneration Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 318 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Abraham, C. A. Henrikson, L. Tung, M. G. Chang, M. Aon, T. Xue, R. A. Li, B. O' Rourke, and E. Marban Antiarrhythmic Engineering of Skeletal Myoblasts for Cardiac Transplantation Circ. Res., July 22, 2005; 97(2): 159 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Ott, R. Kroess, N. Bonaros, R. Marksteiner, E. Margreiter, T. Schachner, G. Laufer, and S. Hering Intramyocardial microdepot injection increases the efficacy of skeletal myoblast transplantation Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1017 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fazel, G. H.L. Tang, D. Angoulvant, M. Cimini, R. D. Weisel, R.-K. Li, and T. M. Yau Current Status of Cellular Therapy for Ischemic Heart Disease Ann. Thorac. Surg., June 1, 2005; 79(6): S2238 - S2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Schachinger and A. M. Zeiher Stem Cells and Cardiovascular and Renal Disease: Today and Tomorrow J. Am. Soc. Nephrol., March 1, 2005; 16(3_suppl_1): S2 - S6. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Wollert and H. Drexler Clinical Applications of Stem Cells for the Heart Circ. Res., February 4, 2005; 96(2): 151 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsuura, H. Wada, T. Nagai, Y. Iijima, T. Minamino, M. Sano, H. Akazawa, J. D. Molkentin, H. Kasanuki, and I. Komuro Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle J. Cell Biol., October 25, 2004; 167(2): 351 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pouly, A. A. Hagege, J.-T. Vilquin, A. Bissery, A. Rouche, P. Bruneval, D. Duboc, M. Desnos, M. Fiszman, Y. Fromes, et al. Does the Functional Efficacy of Skeletal Myoblast Transplantation Extend to Nonischemic Cardiomyopathy? Circulation, September 21, 2004; 110(12): 1626 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Chachques, F. Duarte, B. Cattadori, A. Shafy, N. Lila, G. Chatellier, J.-N. Fabiani, and A. F. Carpentier Angiogenic growth factors and/or cellular therapy for myocardial regeneration: A comparative study J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 245 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Grove, E. Bruscia, and D. S. Krause Plasticity of Bone Marrow-Derived Stem Cells Stem Cells, July 1, 2004; 22(4): 487 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Lee and R. R. Makkar Stem-Cell Transplantation in Myocardial Infarction: A Status Report Ann Intern Med, May 4, 2004; 140(9): 729 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Reinecke, E. Minami, V. Poppa, and C. E. Murry Evidence for Fusion Between Cardiac and Skeletal Muscle Cells Circ. Res., April 2, 2004; 94(6): e56 - e60. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.C. Ott, N. Bonaros, R. Marksteiner, D. Wolf, E. Margreiter, T. Schachner, G. Laufer, and S. Hering Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 627 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Retuerto, P. Schalch, G. Patejunas, J. Carbray, N. Liu, K. Esser, R. G. Crystal, and T. K. Rosengart Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1041 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Chachques, C. Acar, J. Herreros, J. C. Trainini, F. Prosper, N. D'Attellis, J.-N. Fabiani, and A. F. Carpentier Cellular cardiomyoplasty: clinical application Ann. Thorac. Surg., March 1, 2004; 77(3): 1121 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herreros, F. Prosper, A. Perez, J. J Gavira, M. J. Garcia-Velloso, J. Barba, P. L Sanchez, C. Canizo, G. Rabago, J. M Marti-Climent, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction Eur. Heart J., November 2, 2003; 24(22): 2012 - 2020. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Haider, Y. Lei, J. Shujia, and A./P. E. K. W. Sim Cellular myocardial reconstruction using human myoblasts J. Am. Coll. Cardiol., August 6, 2003; 42(3): 589 - 589. [Full Text] [PDF] |
||||
![]() |
S. V. Raman, G. E. Cooke, P. F. Binkley, S. C. Dudley Jr, M. Narlow, Y. M. Zhang, and C. Hartzell Stem Cell-Derived Cardiomyocytes Demonstrate Arrhythmic Potential * Response Circulation, May 27, 2003; 107 (20): e195 - e195. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |